The River team possess a unique blend of experience and expertise to drive the development of various assets across a range of therapeutic areas.
Witold Hruzewicz
Founding Partner at M&A advisory firm Azimutus, with 18 years of investment banking experience encompassing corporate finance, M&A, venture capital and high technology start-ups.
Paul Brennan
Professor of Medicinal Chemistry and Head of Chemistry of the Alzheimer’s Research UK Oxford Drug Discovery Institute in the Centre for Medicines Discovery at the University of Oxford